- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05803720
HIV Provider Intervention to Address Intersectional Stigma and Medical Mistrust
December 20, 2025 updated by: Lu Dong, RAND
Development of an Online Provider Intervention to Address Intersectional Stigma and Medical Mistrust in People Living With HIV
Intersectional stigma and medical mistrust are prevalent among Black and Latina/Latino Americans living with HIV and are key contributors to racial/ethnic health disparities; yet, there are no evidence-based provider-level interventions available for HIV care providers to address intersectional stigma and medical mistrust with patients.
The investigators propose to develop an online provider intervention, with community stakeholders' input, that provides psychoeducation and skills-building around addressing intersectional stigma and medical mistrust with patients.
The investigators will conduct a pilot randomized controlled trial with 60 HIV care physicians (30/condition) to test the acceptability and feasibility of the online intervention and to determine preliminary effects (against a no-intervention control group) on providers' use of skills and HIV care delivery outcomes at baseline, immediate post, and 6-month follow-up.
Study Overview
Status
Completed
Conditions
Detailed Description
The first aim will be an intervention development process that involves engaging community stakeholders to incorporate their input on the intervention manual and working with a provider training organization to develop an online platform for the initial pilot testing.
The intervention will include psychoeducation and skills-building for providers to address intersectional stigma and mistrust, tailored to HIV care.
This aim will include a usability test of the online intervention in 10 HIV clinical care providers.
The second aim will be to conduct a pilot randomized controlled trial to compare two conditions (i.e., online provider intervention versus no-intervention control) on provider training outcomes (e.g., providers' use of skills learned in the intervention) and HIV care delivery outcomes (e.g., the estimated percentage of patients lost to care in the past year) measured at baseline, immediate post-intervention, and 6-month follow-up.
Clinical providers (N = 60) providing care for patients living with HIV will be randomly assigned to the online provider intervention (n = 30) or control with no intervention (n = 30).
The intervention will be delivered in groups (5-10 providers per group).
A mixed-methods process evaluation at immediate post-intervention will determine the acceptability, feasibility, and appropriateness of the intervention, and will be used to refine the intervention.
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90401
- RAND Corporation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- clinical providers (including physicians, physician assistants, nurse practitioners, registered nurses/case managers) caring for patients living with HIV,
- the majority of their patients are from racial/ethnic and sexual minority groups,
- can make the time commitment to participate in the study.
Exclusion Criteria:
- not HIV clinical providers
- cannot make the time commitment to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
No intervention control
|
|
|
Experimental: Provider Intervention
The intervention will consist of psychoeducation and skills-building for HIV care providers to gain the knowledge and skills needed to address intersectional stigma and medical mistrust with patients.
The intervention will be online and conducted in groups.
|
The intervention will consist of psychoeducation and skills-building for HIV care providers to gain knowledge and skills needed to address intersectional stigma and medical mistrust with patients.
The intervention will be online and conducted in groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Helpful/Empathetic Responses Toward Medial Mistrust in Hypothetical Patient Scenarios
Time Frame: Baseline, 2-monts after the baseline assessment, and 6-month follow-up
|
Helpful/empathic responses will be operationalized as the number of motivational interviewing (MI)-consistent statements and validation used in the written responses; this variable will be obtained by coding the responses to the Helpful Response Questionnaire using the Motivational Interviewing Skills Coding for the number of validation and MI-consistent statements used in the written response.
This measure is a count variable and the values ranging above or equal to 0 (no maximum).
Higher values represent a better outcome.
|
Baseline, 2-monts after the baseline assessment, and 6-month follow-up
|
|
Provider Use of Strategies Learned in the Provider Intervention in a Role-play Simulation of Hypothetical Patient Scenarios
Time Frame: Baseline and 2-month after the baseline assessment
|
Provider use of strategies learned in the provider intervention in a role-play simulation will be obtained through coding that will be developed specifically for this study based on existing coding schemes (e.g., Motivational Interviewing Skills Coding, as appropriate).
This variable will be calculated as the total number of training-consistent strategies used during the role-play simulation.
This measure is a count variable and the values ranging above or equal to 0 (no maximum).
Higher values represent a better outcome.
|
Baseline and 2-month after the baseline assessment
|
|
Provider Use of Strategies Learned in the Provider Intervention in a Role-play Simulation of Hypothetical Patient Scenarios
Time Frame: Baseline and 2-month after the baseline assessment
|
Provider use of strategies learned in the provider intervention in a role-play simulation will be obtained through coding that will be developed specifically for this study based on existing coding schemes (e.g., Motivational Interviewing Skills Coding, as appropriate).
This variable will be calculated as the total number of training-inconsistent strategies used during the role-play simulation.
This measure is a count variable and the values ranging above or equal to 0 (no maximum).
Higher values represent a better outcome.
|
Baseline and 2-month after the baseline assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lu Dong, PhD, RAND
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Actual)
March 31, 2024
Study Completion (Actual)
March 31, 2025
Study Registration Dates
First Submitted
February 14, 2023
First Submitted That Met QC Criteria
March 25, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
December 23, 2025
Last Update Submitted That Met QC Criteria
December 20, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-N0035
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stigma, Social
-
Ohio State UniversityNational Center for Advancing Translational Sciences (NCATS); Howard University and other collaboratorsEnrolling by invitation
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)Completed
-
Washington University School of MedicineUniversity of North Carolina, Chapel Hill; Nigerian Institute of Medical ResearchCompleted
-
Yuzuncu Yil UniversityCompletedParental Stress | StigmaTurkey (Türkiye)
-
Emory UniversityNational Institute of Nursing Research (NINR)RecruitingPsychological Distress | Stigma, SocialUnited States
-
Tokyo UniversityNot yet recruitingMental Health Literacy | Help-seeking Intention | Stigma (Social Distance)
-
University of ChicagoPlanned Parenthood Federation of AmericaCompleted
-
Sheba Medical CenterCompleted
-
University of TorontoCompletedSocial StigmaLesotho, Swaziland
-
Duke UniversityNational Institutes of Health (NIH); Fogarty International Center of the National...Recruiting
Clinical Trials on Provider Intervention on Addressing Intersectional Stigma and Medical Mistrust in Patients with HIV
-
Philipps University Marburg Medical CenterCompleted
-
Yating LiuCompletedHypoglycemia | Type 2 Diabetes Mellitus | Health EducationChina
-
Norwegian Institute of Public HealthUniversity of Oslo; Oslo University Hospital; Oslo MunicipalityActive, not recruitingHip Fractures | Fall Injury